Attached files

file filename
8-K/A - 8-K/A - Prestige Consumer Healthcare Inc.v309197_8ka.htm
EX-99.2 - EXHIBIT 99.2 - Prestige Consumer Healthcare Inc.v309197_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - Prestige Consumer Healthcare Inc.v309197_ex99-1.htm

 Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-123487) of Prestige Brands Holdings, Inc. of our report dated 9 March 2012 relating to the financial statements of The North American Divested Brands of GlaxoSmithKline Plc, which appears in this Current Report on Form 8-K of Prestige Brands Holdings, Inc.

 

 

 

 

 

 

/s/ PricewaterhouseCoopers LLP 

PricewaterhouseCoopers LLP
London

16 April 2012

 

 

 

 

 

 

 

PricewaterhouseCoopers LLP, 1 Embankment Place, London WC2N 6RH

T: +44 (0) 20 7583 5000, F: +44 (0) 20 7212 4652, www.pwc.co.uk

 

PricewaterhouseCoopers LLP is a limited liability partnership registered in England with registered number OC303525. The registered office of

PricewaterhouseCoopers LLP is 1 Embankment Place, London WC2N 6RH.PricewaterhouseCoopers LLP is authorised and regulated by the Financial Services Authority for designated investment business.